These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

550 related items for PubMed ID: 22194472

  • 1. A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing.
    Ju YS, Lee WC, Shin JY, Lee S, Bleazard T, Won JK, Kim YT, Kim JI, Kang JH, Seo JS.
    Genome Res; 2012 Mar; 22(3):436-45. PubMed ID: 22194472
    [Abstract] [Full Text] [Related]

  • 2. KIF5B/RET fusion gene in surgically-treated adenocarcinoma of the lung.
    Yokota K, Sasaki H, Okuda K, Shimizu S, Shitara M, Hikosaka Y, Moriyama S, Yano M, Fujii Y.
    Oncol Rep; 2012 Oct; 28(4):1187-92. PubMed ID: 22797671
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic method for the detection of KIF5B-RET transformation in lung adenocarcinoma.
    Go H, Jung YJ, Kang HW, Park IK, Kang CH, Lee JW, Ju YS, Seo JS, Chung DH, Kim YT.
    Lung Cancer; 2013 Oct; 82(1):44-50. PubMed ID: 23932363
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. KIF5B/RET fusion gene analysis in a selected series of cytological specimens of EGFR, KRAS and EML4-ALK wild-type adenocarcinomas of the lung.
    Borrelli N, Giannini R, Proietti A, Alì G, Pelliccioni S, Niccoli C, Lucchi M, Melfi F, Mussi A, Basolo F, Fontanini G.
    Lung Cancer; 2013 Sep; 81(3):377-381. PubMed ID: 23891510
    [Abstract] [Full Text] [Related]

  • 6. Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions.
    Suehara Y, Arcila M, Wang L, Hasanovic A, Ang D, Ito T, Kimura Y, Drilon A, Guha U, Rusch V, Kris MG, Zakowski MF, Rizvi N, Khanin R, Ladanyi M.
    Clin Cancer Res; 2012 Dec 15; 18(24):6599-608. PubMed ID: 23052255
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Molecular mechanisms underlying oncogenic RET fusion in lung adenocarcinoma.
    Mizukami T, Shiraishi K, Shimada Y, Ogiwara H, Tsuta K, Ichikawa H, Sakamoto H, Kato M, Shibata T, Nakano T, Kohno T.
    J Thorac Oncol; 2014 May 15; 9(5):622-30. PubMed ID: 24722152
    [Abstract] [Full Text] [Related]

  • 11. RET, ROS1 and ALK fusions in lung cancer.
    Takeuchi K, Soda M, Togashi Y, Suzuki R, Sakata S, Hatano S, Asaka R, Hamanaka W, Ninomiya H, Uehara H, Lim Choi Y, Satoh Y, Okumura S, Nakagawa K, Mano H, Ishikawa Y.
    Nat Med; 2012 Feb 12; 18(3):378-81. PubMed ID: 22327623
    [Abstract] [Full Text] [Related]

  • 12. Potential Unreliability of Uncommon ALK, ROS1, and RET Genomic Breakpoints in Predicting the Efficacy of Targeted Therapy in NSCLC.
    Li W, Guo L, Liu Y, Dong L, Yang L, Chen L, Liu K, Shao Y, Ying J.
    J Thorac Oncol; 2021 Mar 12; 16(3):404-418. PubMed ID: 33248323
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. CD74-ROS1 fusion transcripts in resected non-small cell lung carcinoma.
    Matsuura S, Shinmura K, Kamo T, Igarashi H, Maruyama K, Tajima M, Ogawa H, Tanahashi M, Niwa H, Funai K, Kohno T, Suda T, Sugimura H.
    Oncol Rep; 2013 Oct 12; 30(4):1675-80. PubMed ID: 23877438
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A single-tube multiplexed assay for detecting ALK, ROS1, and RET fusions in lung cancer.
    Lira ME, Choi YL, Lim SM, Deng S, Huang D, Ozeck M, Han J, Jeong JY, Shim HS, Cho BC, Kim J, Ahn MJ, Mao M.
    J Mol Diagn; 2014 Mar 12; 16(2):229-43. PubMed ID: 24418728
    [Abstract] [Full Text] [Related]

  • 20. RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancer.
    Wang R, Hu H, Pan Y, Li Y, Ye T, Li C, Luo X, Wang L, Li H, Zhang Y, Li F, Lu Y, Lu Q, Xu J, Garfield D, Shen L, Ji H, Pao W, Sun Y, Chen H.
    J Clin Oncol; 2012 Dec 10; 30(35):4352-9. PubMed ID: 23150706
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.